Weight Loss in Obese Children and Adolescents and Its Effect on Improvement of Destructive Changes in Blood Vessels
1 other identifier
interventional
180
1 country
1
Brief Summary
Obesity in children and adolescents is associated with morphologic and functional changes of the vascular wall, suggesting a potential role of juvenile obesity for the development of atherosclerosis later in life. However, no evidence from intervention studies has been provided so far that weight loss in obese children can improve vascular function. Therefore we designed this study including a cohort of obese children before and after a structured weight reduction program in order to answer the question, whether such an intervention can improve vascular function and reverse destructive vascular changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2007
CompletedFirst Posted
Study publicly available on registry
February 26, 2007
CompletedStudy Start
First participant enrolled
April 1, 2007
CompletedMay 9, 2007
March 1, 2007
February 22, 2007
May 8, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
changes in flow-mediated dilation of the brachial artery
intima media thickness of the brachial artery
Secondary Outcomes (1)
weight reduction
Interventions
Eligibility Criteria
You may qualify if:
- children between 7 and 10 years with tanner 0 or 13 to 17 years with tanner 4 or 5
- body mass index \> 97th percentile
You may not qualify if:
- severe medical disorders in addition to obesity
- severe psychosocial impairments
- known endocrine or genetic causes for obesity
- family history of premature cardiovascular disease
- factors affecting vascular function, including cigarette smoking
- regular medication for other diseases including vitamin supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Heidelberg, Department of Internal Medicine I
Heidelberg, 69120, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joerg Tafel, Dr
University Hospital Heidelberg, Department of Internal Medicine I
- STUDY CHAIR
Peter P Nawroth, Prof
University Hospital Heidelberg, Department of Internal Medicine I
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 22, 2007
First Posted
February 26, 2007
Study Start
April 1, 2007
Last Updated
May 9, 2007
Record last verified: 2007-03